PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 162 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,078,709 | +2962.8% | 488,468 | +4147.5% | 0.01% | – |
| Q1 2023 | $133,170 | -78.3% | 11,500 | -84.7% | 0.00% | -100.0% |
| Q4 2022 | $614,318 | +18.1% | 75,100 | -16.2% | 0.00% | 0.0% |
| Q3 2022 | $520,000 | -63.9% | 89,600 | -38.6% | 0.00% | -88.9% |
| Q3 2020 | $1,441,000 | +181.4% | 146,005 | -1.5% | 0.01% | +125.0% |
| Q2 2020 | $512,000 | -10.3% | 148,261 | -20.6% | 0.00% | -33.3% |
| Q1 2020 | $571,000 | -61.4% | 186,617 | -35.1% | 0.01% | -40.0% |
| Q4 2019 | $1,478,000 | -57.1% | 287,644 | -56.9% | 0.01% | -63.0% |
| Q3 2019 | $3,448,000 | +109.6% | 668,137 | +145.7% | 0.03% | +92.9% |
| Q2 2019 | $1,645,000 | -88.1% | 271,957 | -85.8% | 0.01% | -78.5% |
| Q1 2019 | $13,842,000 | +201.7% | 1,914,428 | +208.8% | 0.06% | +38.3% |
| Q4 2018 | $4,588,000 | – | 620,001 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |